These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32539539)

  • 21. Protection for manufacturing, not research.
    Nat Rev Drug Discov; 2003 Oct; 2(10):766. PubMed ID: 14579809
    [No Abstract]   [Full Text] [Related]  

  • 22. Preparing effective experimental data for pharmaceutical patent applications from US and Japanese perspectives.
    Altman D; Sweeney C; Yasui T
    Pharm Pat Anal; 2014 Sep; 3(5):469-73. PubMed ID: 25374314
    [No Abstract]   [Full Text] [Related]  

  • 23. Biotechnology products and university-based science.
    Korn D; Heinig SJ
    JAMA; 2005 Jun; 293(23):2862-3; author reply 2863. PubMed ID: 15956628
    [No Abstract]   [Full Text] [Related]  

  • 24. Amgen cholesterol antibody feud could kill key IP rule.
    Ratner M
    Nat Biotechnol; 2017 Dec; 35(12):1118-1119. PubMed ID: 29220019
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmaceutical patent challenges--time for reassessment?
    Glass G
    Nat Rev Drug Discov; 2004 Dec; 3(12):1057-62. PubMed ID: 15573104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent patent applications in angiogenesis research.
    Nat Biotechnol; 2006 Feb; 24(2):155. PubMed ID: 16465155
    [No Abstract]   [Full Text] [Related]  

  • 27. Patent watch: one valid claim is all that is needed.
    Harrison C
    Nat Rev Drug Discov; 2013 Jun; 12(6):416-7. PubMed ID: 23722337
    [No Abstract]   [Full Text] [Related]  

  • 28. Using market-exclusivity incentives to promote pharmaceutical innovation.
    Kesselheim AS
    N Engl J Med; 2010 Nov; 363(19):1855-62. PubMed ID: 21047231
    [No Abstract]   [Full Text] [Related]  

  • 29. Patent reform in the US: what's at stake for pharmaceutical innovation?
    Yancey A; Stewart CN
    Expert Opin Ther Pat; 2010 May; 20(5):603-8. PubMed ID: 20402544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene patenting and medical research: a view from a pharmaceutical company.
    Stott M; Valentine J
    Nat Rev Drug Discov; 2004 Apr; 3(4):364-8. PubMed ID: 15060532
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmaceutical patent law: the Canadian perspective.
    Aumand L; Norman J
    Pharm Pat Anal; 2016 Jul; 5(4):271-9. PubMed ID: 27346187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are patents impeding medical care and innovation?
    Gold ER; Kaplan W; Orbinski J; Harland-Logan S; N-Marandi S
    PLoS Med; 2010 Jan; 7(1):e1000208. PubMed ID: 20052274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patent protection for medical technologies: why some and not others?
    Melzer D
    Lancet; 1998 Feb; 351(9101):518-9. PubMed ID: 9482467
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug patents and other ways to protect pharmaceutical research].
    Ohana P; Tardieu S; Blin O; Tassy S; Sambuc R
    Therapie; 2004; 59(2):253-7. PubMed ID: 15359623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug discovery market exclusivity after KSR: the challenge to pharmaceutical scientists and the US congress.
    Wolff ME
    J Pharm Sci; 2011 Aug; 100(8):3044-3054. PubMed ID: 21472728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Panel rules against Canada on patent terms for pre-TRIPS patents.
    Elliott R
    Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):43, 45. PubMed ID: 11833196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [SCHWABE Company's patent portfolio of Ginkgo biloba preparation].
    Liu W; Cheng XM; Geng DM; Tan W; Zou WJ
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3384-8. PubMed ID: 25522634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intellectual property. Fixing the legal framework for pharmaceutical research.
    Knowles SM
    Science; 2010 Feb; 327(5969):1083-4. PubMed ID: 20150445
    [No Abstract]   [Full Text] [Related]  

  • 39. Three drugs facing key patent expirations and potential generic entry from June 2020 to July 2020.
    Friedman Y
    Pharm Pat Anal; 2020 May; 9(3):75-76. PubMed ID: 32539666
    [No Abstract]   [Full Text] [Related]  

  • 40. Biotech reels over patent ruling.
    Check-Hayden E
    Nature; 2014 Jul; 511(7508):138. PubMed ID: 25008505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.